The following text is from the May 25, 2023 press release from ASTM:
Global standards organization ASTM International and Doctors for Drug Policy Reform (formerly Doctors for Cannabis Regulation) have signed a memorandum of understanding (MoU) aimed at the continued development of ASTM standards for cannabis.
The MoU was signed by Bryon Adinoff, DFCR president, and Dan Smith, ASTM International’s vice president of technical committee operations.
DFCR’s founder and past president, Dr. David Nathan, who is also an ASTM member and a major contributor to ASTM D8441 (the consensus standard defining the International Intoxicating Cannabinoid Product Symbol), is delighted by this development. “Within the community of consensus standard organizations, ASTM leads the world in the development of cannabis regulatory standards,” Nathan said. “This MoU reflects the close alignment of goals between ASTM and DFCR. Together, we will design industry standards that serve the interests of public health, consumer protections, and public safety.”
As part of the agreed upon MoU:
“At ASTM, we are always excited to have unique voices take part in the standards development process,” notes Smith. “We welcome Doctors for Cannabis Regulation, and their robust expertise they continue to bring to the development of ASTM cannabis standards.”
ASTM International’s cannabis committee (D37) was formed in 2017 to develop standards for cannabis, its products, and processes. To learn more about the work of the committee and ASTM’s other efforts in the cannabis space, visit https://www.astmcannabis.org/.
ASTM International is a not-for-profit nongovernmental organization that develops voluntary consensus standards and defers to appropriate government authorities to determine the legal and regulatory framework regarding the control and use of cannabis.
ASTM Media Inquiries: Dan Bergels, tel +1.610.832.9602; firstname.lastname@example.org
DFCR Media Inquiries: email@example.com